Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Lymphoma, Large B-Cell, Diffuse 81Leukemia, Myeloid, Acute 75Multiple Myeloma 72Breast Neoplasms 70Lymphoma, Non-Hodgkin 64Lymphoma 64Burkitt Lymphoma 54Leukemia, Lymphocytic, Chronic, B-Cell 53Myelodysplastic Syndromes 50Recurrence 49Lymphoma, Follicular 49Lymphoma, B-Cell 48Leukemia 42Triple Negative Breast Neoplasms 41Lymphoma, Mantle-Cell 38Neoplasms 37Hodgkin Disease 35Melanoma 34Hematologic Neoplasms 33Lymphoma, B-Cell, Marginal Zone 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Neuroblastoma 28Ovarian Neoplasms 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Neoplasm Metastasis 22Leukemia, Biphenotypic, Acute 21Pancreatic Neoplasms 20Sarcoma 18Leukemia, Myelomonocytic, Chronic 17

Interventions

Carboplatin 5pembrolizumab 3Paclitaxel 3Observation 3Capecitabine 3Azacitidine 3venetoclax 2pertuzumab 2olaparib 2durvalumab 2Tretinoin 2Trastuzumab 2Standard of Care 2Oxaliplatin 2Irinotecan 2Immunotherapy 2Chemoradiotherapy 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1toripalimab 1tislelizumab 1tegafur-gimeracil-oteracil 1taxane 1talazoparib 1tagraxofusp 1sarilumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Cyclophosphamide × 1 year × Clear all
NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Lund University Hospital

Phase 3 Active not recruiting
325 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡